BSPM — Biostar Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -20 | 0.809 | 4.85 | -25.1 | -5.7 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 10.3 | 2.1 | 6.31 | 21.6 | -0.265 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 6.3 | 2.24 | -6.65 | 5.76 | 7.08 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3.58 | 8.91 | 3.31 | 5.88 | 4.91 |
Capital Expenditures | -8.75 | -0.982 | -2.87 | -0.059 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -8.54 | -3.23 | -6.01 | -7.32 | -6.38 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -17.3 | -4.21 | -8.88 | -7.38 | -6.38 |
Financing Cash Flow Items | 1.58 | -1.61 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.55 | -6.46 | 6.95 | -0.161 | 1.41 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -15.2 | -1.68 | 1.61 | -1.65 | 0.134 |